Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
Clinical trial NCT05534087 · RECRUITING
Trial details
- NCT number
- NCT05534087
- Sponsor
- Seoul National University Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2028-09-30
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.